Cargando…
PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
The tumor recurrence and drug resistance of hepatocellular carcinoma (HCC) threatened patients a lot. The mechanism should be further explored. The information of expression status and survival were available in public databases. The Western blot and immunohistochemistry staining displayed the level...
Autores principales: | Zhang, Hanpu, Li, Chenyuan, Liao, Shichong, Tu, Yi, Sun, Shengrong, Yao, Feng, Li, Zhiyu, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519003/ https://www.ncbi.nlm.nih.gov/pubmed/36137220 http://dx.doi.org/10.1080/15384047.2022.2125260 |
Ejemplares similares
-
PSMD12 promotes glioma progression by upregulating the expression of Nrf2
por: Wang, Zhongyong, et al.
Publicado: (2021) -
KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
por: Zhao, Hongda, et al.
Publicado: (2019) -
KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway
por: Wang, Jie, et al.
Publicado: (2017) -
High Glucose Accelerates Tumor Progression by Regulating MEDAG-Mediated Autophagy Levels in Breast Cancer
por: Li, Chenyuan, et al.
Publicado: (2022) -
KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis
por: Zhang, Ruiyun, et al.
Publicado: (2022)